|
US2086186A
(en)
|
1933-10-10 |
1937-07-06 |
Us Rubber Co |
Treatment of rubber
|
|
GB1435721A
(en)
|
1972-05-18 |
1976-05-12 |
Lilly Industries Ltd |
Benzoxazole derivatives
|
|
SU509046A1
(ru)
|
1975-02-21 |
1984-06-23 |
Всесоюзный научно-исследовательский химико-фармацевтический институт им.Серго Орджоникидзе |
Производные 2-карбэтокси-3-аминоиндола,про вл ющие противовоспалительную активность, и способ их получени
|
|
US4675332A
(en)
|
1984-12-10 |
1987-06-23 |
Warner-Lambert Company |
Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
|
|
GB8610981D0
(en)
|
1986-05-06 |
1986-06-11 |
Ici America Inc |
Quinoline amides
|
|
AU641052B2
(en)
|
1990-11-02 |
1993-09-09 |
Aventisub Ii Inc. |
3-amidoindolyl derivatives
|
|
US5668117A
(en)
|
1991-02-22 |
1997-09-16 |
Shapiro; Howard K. |
Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
|
|
US20050090553A1
(en)
|
1992-06-30 |
2005-04-28 |
Shapiro Howard K. |
Compositions and method for treatment of chronic inflammatory diseases
|
|
US6444221B1
(en)
|
1992-06-30 |
2002-09-03 |
Howard K. Shapiro |
Methods of treating chronic inflammatory diseases using carbonyl trapping agents
|
|
US5472954A
(en)
|
1992-07-14 |
1995-12-05 |
Cyclops H.F. |
Cyclodextrin complexation
|
|
US5493027A
(en)
|
1993-01-22 |
1996-02-20 |
Board Of Regents, The University Of Texas System |
Anticonvulsive agents and uses thereof
|
|
US5597823A
(en)
|
1995-01-27 |
1997-01-28 |
Abbott Laboratories |
Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists
|
|
US5742954A
(en)
|
1996-11-22 |
1998-04-28 |
Softub, Inc. |
Electrically powered spa jet unit
|
|
ATE336485T1
(de)
|
1997-05-02 |
2006-09-15 |
Schering Ag |
Substituierte heterocyclen und deren verwendung in arzneimitteln
|
|
WO1999046237A1
(en)
|
1998-03-12 |
1999-09-16 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases
|
|
US6498154B1
(en)
|
1999-05-04 |
2002-12-24 |
Wyeth |
Cyclic regimens using quinazolinone and benzoxazine derivatives
|
|
AU1735001A
(en)
|
1999-12-10 |
2001-06-18 |
Senju Pharmaceutical Co., Ltd. |
Cyclodextrin-containing pharmaceutical composition
|
|
US6569879B2
(en)
*
|
2000-02-18 |
2003-05-27 |
Merck & Co., Inc. |
Aryloxyacetic acids for diabetes and lipid disorders
|
|
FR2827599A1
(fr)
|
2001-07-20 |
2003-01-24 |
Neuro3D |
Composes derives de quinoleine et quinoxaline,preparation et utilisations
|
|
UA83620C2
(ru)
|
2001-12-05 |
2008-08-11 |
Уайт |
Замещенные бензоксазолы и их аналоги как эстрогенные агенты
|
|
CA2451267A1
(en)
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
JP2006520393A
(ja)
|
2003-03-14 |
2006-09-07 |
ユニバーシティ オブ ワシントン |
レチノイド補充物およびオプシンアゴニスト、ならびにそれらの使用法
|
|
EP2292239A3
(en)
|
2003-04-18 |
2011-03-30 |
Advanced Medicine Research Institute |
Remedies for diseases to be applied to eye
|
|
US20060111318A1
(en)
|
2003-04-18 |
2006-05-25 |
Advanced Medicine Research Institute |
Agent for treating eye diseases
|
|
US20040235892A1
(en)
|
2003-05-22 |
2004-11-25 |
Yujia Dai |
Indazole and benzisoxazole kinase inhibitors
|
|
US7297709B2
(en)
*
|
2003-05-22 |
2007-11-20 |
Abbott Laboratories |
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
|
|
TWI344961B
(en)
|
2003-10-15 |
2011-07-11 |
Ube Industries |
Novel indazole derivative
|
|
AU2004293105B2
(en)
|
2003-11-20 |
2010-09-09 |
Othera Holding, Inc. |
Amelioration of macular degeneration and other ophthalmic diseases
|
|
US20050197292A1
(en)
|
2004-01-30 |
2005-09-08 |
Glennda Smithson |
Compositions and methods for treating T-cell mediated pathological conditions
|
|
US20080176952A1
(en)
|
2004-02-17 |
2008-07-24 |
Rando Robert R |
Management of Ophthalmologic Disorders, Including Macular Degeneration
|
|
US20050234018A1
(en)
|
2004-04-15 |
2005-10-20 |
Allergan, Inc. |
Drug delivery to the back of the eye
|
|
WO2006002473A1
(en)
|
2004-07-02 |
2006-01-12 |
Adelaide Research & Innovation Pty Ltd |
Method of controlling damage mediated by alpha, beta-unsaturated aldehydes
|
|
JP2008518913A
(ja)
|
2004-10-28 |
2008-06-05 |
メルク エンド カムパニー インコーポレーテッド |
代謝調節型グルタミン酸受容体のピリミジン及びキノリン増強因子
|
|
TW200640443A
(en)
|
2005-02-23 |
2006-12-01 |
Alcon Inc |
Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors
|
|
CA2609659C
(en)
|
2005-05-26 |
2014-01-28 |
Neuron Systems, Inc. |
Azanaphthalenes, compositions and methods for treating retinal disease
|
|
JP5290147B2
(ja)
|
2006-04-14 |
2013-09-18 |
プラナ バイオテクノロジー リミティッド |
加齢黄斑変性症（ａｍｄ）の処置方法
|
|
CN101611009A
(zh)
|
2006-07-25 |
2009-12-23 |
伊维沃制药股份有限公司 |
喹啉衍生物
|
|
MX337100B
(es)
|
2007-10-05 |
2016-02-11 |
Acucela Inc |
Compuestos alcoxi para el tratamiento de enfermedades.
|
|
US20120108585A1
(en)
*
|
2008-08-12 |
2012-05-03 |
Sirtris Pharmaceuticals, Inc. |
Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators
|
|
WO2010133672A1
(en)
|
2009-05-20 |
2010-11-25 |
Clanotech Ab |
Derivatives of quinoline-3-carboxylic acid and their medical use
|
|
EP2477594A4
(en)
|
2009-07-15 |
2013-03-13 |
Univ Vanderbilt |
ISOKETAL CATCHER AND TREATMENT OF DISEASES WITH OXIDATIVE INJURY
|
|
ES2758554T3
(es)
|
2009-12-08 |
2020-05-05 |
Univ Case Western Reserve |
Aminoácidos gama para tratamiento de trastornos oculares
|
|
CA2782015C
(en)
*
|
2009-12-11 |
2020-08-25 |
Neuron Systems, Inc. |
Topical ophthalmic compositions and methods for the treatment of macular degeneration
|
|
EP3208263A1
(en)
|
2011-01-12 |
2017-08-23 |
VentiRx Pharmaceuticals, Inc. |
Substituted benzoazepines as toll-like receptor modulators
|
|
WO2012105887A1
(en)
|
2011-01-31 |
2012-08-09 |
Tim Bowden |
Active principle for mitigating undesired medical conditions
|
|
HK1217325A1
(zh)
|
2012-12-20 |
2017-01-06 |
奥尔德拉医疗公司 |
迫位原醇
|
|
AU2014209387B2
(en)
|
2013-01-23 |
2018-11-01 |
Aldeyra Therapeutics, Inc. |
Toxic aldehyde related diseases and treatment
|